Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This prospective study aimed to compare the clinical outcomes between the use of the erbium:
YAG (Er:YAG) laser, intraurethrally administered in long non-ablative SMOOTH™ train of pulses
applied at the level of the male prostatic urethra, to the use of the pharmacological
treatment of oral tadalafil for the treatment of chronic prostatitis/chronic pelvic pain
syndrome (CP/CPPS). The results show that both treatments are effective in alleviating
symptoms of CP/CPPS. The non-ablative Er:YAG SMOOTHTM laser seems to be a promising treatment
for this widely spread condition. More studies are needed to confirm its safety and efficacy.